Literature DB >> 29491037

Unclassifiable interstitial lung disease: a pathologist's perspective.

Kirk D Jones1.   

Abstract

Classifying pulmonary fibrotic disease into various diagnostic categories provides the clinician with expectations for both prognosis and proper treatment. Despite years of experience with histological, radiological and clinical guidelines, a group of patients remains with unclassifiable interstitial lung disease. In this article, the possible barriers to classification will be explored, and some strategies will be discussed to aid in overcoming these barriers.
Copyright ©ERS 2018.

Entities:  

Mesh:

Year:  2018        PMID: 29491037     DOI: 10.1183/16000617.0132-2017

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  5 in total

1.  Structural Refinement of the Tubulin Ligand (+)-Discodermolide to Attenuate Chemotherapy-Mediated Senescence.

Authors:  Boying Guo; Alicia Rodriguez-Gabin; Andrea E Prota; Tobias Mühlethaler; Nan Zhang; Kenny Ye; Michel O Steinmetz; Susan Band Horwitz; Amos B Smith; Hayley M McDaid
Journal:  Mol Pharmacol       Date:  2020-06-26       Impact factor: 4.436

Review 2.  Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease.

Authors:  Nevins W Todd; Sergei P Atamas; Stella E Hines; Irina G Luzina; Nirav G Shah; Edward J Britt; Andrew J Ghio; Jeffrey R Galvin
Journal:  Expert Rev Respir Med       Date:  2022-01-31       Impact factor: 3.772

Review 3.  Recent Advances in Molecular Diagnosis of Pulmonary Fibrosis for Precision Medicine.

Authors:  Mi Ho Jeong; Hongwei Han; David Lagares; Hyungsoon Im
Journal:  ACS Pharmacol Transl Sci       Date:  2022-07-20

4.  A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease.

Authors:  Neal Dodia; Diana Amariei; Blaine Kenaa; Doug Corwin; Lydia Chelala; E James Britt; Ashutosh Sachdeva; Irina G Luzina; Jeffrey D Hasday; Nirav G Shah; Sergei P Atamas; Teri J Franks; Allen P Burke; Stella E Hines; Jeffrey R Galvin; Nevins W Todd
Journal:  Respir Med       Date:  2021-02-11       Impact factor: 3.415

5.  Clinical characteristics of COVID-19 in patients with preexisting ILD: A retrospective study in a single center in Wuhan, China.

Authors:  Hong Huang; Ming Zhang; Can Chen; Huilan Zhang; Yanqiu Wei; Jianbo Tian; Jin Shang; Yan Deng; Aihua Du; Huaping Dai
Journal:  J Med Virol       Date:  2020-08-02       Impact factor: 20.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.